๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Current applications of monoclonal antibodies for the therapy of hematopoietic cancers

โœ Scribed by David A. Scheinberg

Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
803 KB
Volume
3
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

โœฆ Synopsis

Recent trials of monoclonal antibodies in patients with leukemias or lymphomas have demonstrated the remarkable potency of these agents to kill tumor cells specifically and safely. New molecular biological and radiochemical techniques are also allowing rapid inroads into the remaining obstacles to this mode of therapy.

๐Ÿ“œ SIMILAR VOLUMES

Monoclonal antibodies in the study and t
Monoclonal antibodies in the study and therapy of hematopoietic cancers
โœ Dana C Matthews; Franklin O Smith; Irwin D Bernstein ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 904 KB

Recent advances utilizing monoclonal antibodies to phenotype acute leukemias have revealed no prognostic significance of the expression of lymphoid-associated antigens by acute myeloid leukemia blasts and conflicting results regarding 'biphenotypic' acute myeloid leukemia. Several studies treating p

Use of syngeneic monoclonal antibodies i
Use of syngeneic monoclonal antibodies in the therapy of disseminated myeloid leukemic cells
โœ D. Berends; A. H. Mulder; G. van Houwelingen; N. J. de Both ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 653 KB

A syngeneic monoclonal antibody (MAb) (IC5F5) was SUC-in RPMI 1640 + 10% fetal calf serum (Seromed, Miles, Brus-cessfully used in the immunotherapy of Rauxher-virus-in-sels). duced myeloid leukemic RMB-I cells. It is directed to a virusencoded, but aberrantly processed protein, which is expressed Mi